Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Mar 14:2:79-84.
doi: 10.1016/j.mmcr.2013.02.008.

Mind the gap: Management of an emergent and threatening invasive fungal infection-a case report of rhino-orbital-cerebral and pulmonary mucormycosis

Affiliations

Mind the gap: Management of an emergent and threatening invasive fungal infection-a case report of rhino-orbital-cerebral and pulmonary mucormycosis

Joana Cortez et al. Med Mycol Case Rep. .

Abstract

Mucormycosis is an emergent and threatening invasive fungal invasion underdiagnosed by clinicians due to lack of awareness and aspecific clinical picture. The authors describe a clinical case of a diabetic and cirrhotic patient who developed rhino-orbital-cerebral and pulmonary mucormycosis, non-responsive to treatment. Typical gaps in the management of this deadly disease are addressed. There is a strong need for novel therapies and an expectation that sponsors will recognize the critical need for randomized clinical trials.

Keywords: Delays; Diabetes; High mortality; Hyperbaric medicine; Mucormycosis; Randomized clinical trials.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Cerebral CT scan, axial images. (A–C), Non-enhanced CT scan; (D) Contrast-enhanced CT scan. Partial soft tissue opacification of the maxillary, sphenoid and ethmoid sinuses.
Fig. 2
Fig. 2
Cerebral CT scan, axial images. (A and B) Non-enhanced CT scan; (C) CT scan bone window; (D) Contrast-enhanced CT scan. Soft tissue opacification of the paranasal sinuses associated with focal areas of bone erosion of the posterior wall of the right maxillary sinus (arrowhead). Extension of the soft tissue lesion to the pterygopalatine fossa and intracranial extension to the temporal fossa (arrow) and to the anterior part of the cavernous sinus.
Fig. 3
Fig. 3
Cerebral MRI: (A, B) (axial T1 with fat saturation after gadolinium) and (C) (coronal T1 with fat saturation after gadolinium). Lesion centered on the apex of the right orbit, filling the sphenoidal fissure and optic canal, extending to the pterygopalatine fossa (arrowhead) and with mild intracranial extra-axial extension (arrow). Lesion is isointense in T1 and hypointense in T2 (not shown) with homogeneous enhancement after gadolinium. Associated inflammatory changes of the sinuses are also observed.
Fig. 4
Fig. 4
(A) Hematoxylin and eosin stain, 400× and (B) Grocott's methenamine silver stain, 400×. Multiple broad non-septated, ribbon-like, right-angle hyphae.
Fig. 5
Fig. 5
(A and B) (Axial T1 with fat saturation after gadolinium) Cerebral MRI at day 20 of Liposomal amphotericin B and caspofungin treatment, showing imagiological worsening with increased intracranial infiltration of the fungal lesion (arrow).
Fig. 6
Fig. 6
Thorax CT scan: muliple peripherical centrilobular nodules with “tree-in-bud” images (arrows), showing endobronchial spread of infection.

References

    1. Kontoyiannis D.P., Lewis R.E., Lotholary O., Spellberg B., Petrikkos G., Roillides E. Future directions in mucormycosis research. Clinical Infectious Diseases. 2012;54(S1):S79–S85. - PMC - PubMed
    1. Marques DS, Pinho Vaz C, Branca R, Campilho F, Lamelas C, Afonso LP et al. Rhizomucor and scedosporium infection post hematopoietic stem-cell transplant. Case Report Med 2011;830769. doi:10.1155/2011/830769. Epub 2011 April 5. - DOI - PMC - PubMed
    1. Oliveira V., Costa A. Cerebral hematoma caused by mucormycosis. Reviews in Neurological Diseases. 2001;33(10):951–953. - PubMed
    1. Rammaert B., Lanternier F., Poirée S., Kania R., Lortholary O. Diabetes and mucormycosis: a complex interplay. Diabetes and Metabolism. 2012;38(3):193–204. - PubMed
    1. Spellberg B., Ibrahim A., Roilides E., Lewis R.E., Lortholary O., Petrikkos G. Combination therapy for mucormycosis: Why, what, and how? Clinical Infectious Diseases. 2012;54(S1):S73–S78. - PMC - PubMed

LinkOut - more resources